While the direct pro-apoptotic role of Bim is well-established, a significant gap in knowledge lies in fully understanding the precise upstream signaling pathways and post-translational modifications that regulate its release from inhibitory complexes in various cancer types, which could inform strategies to unleash its tumor-suppressive activity. Here, BCL2L11 is linked to cancer.